Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|August 10, 2024
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut MicrobiotaPaola Secchiero, Erika Rimondi, Annalisa Marcuzzi, et al.
Oncotarget|June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.
Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.
Nutrients|April 13, 2023
<i>Convolvulus pluricaulis</i> Choisy's Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell ModelElisabetta Melloni, Silvia Grassilli, Arianna Romani, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological InhibitorsErika Rimondi, Elisabetta Melloni, Arianna Romani, et al.
Acta Neurochirurgica|June 23, 2025
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary studyPasquale De Bonis, Francesca Ghidoni, Veronica Tisato, et al.
Experimental Dermatology|August 27, 2025
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation?Annalisa Marcuzzi, Erika Rimondi, Giada Lodi, et al.
Biomolecules|July 29, 2025
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone SkinMuhammad Suleman, Abrar Mohammad Sayaf, Chiara Moltrasio, et al.
Plos One|September 12, 2018
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney diseaseMaria Vittoria Arcidiacono, Erika Rimondi, Elisa Maietti, et al.
Pageof 7